Robert Ezzell
Corporate Officer/Principal en ATAI LIFE SCIENCES N.V. .
Perfil
Robert Ezzell is currently a Senior Director-Regulatory Affairs at ATAI Life Sciences NV since 2021.
Prior to this, he worked as a Director-Product Development at RenaMed Biologics, Inc., a Director-Regulatory Affairs at Glympse Bio, Inc., and an Assistant Professor at Harvard Medical School.
He holds a doctorate degree from the University of California, Berkeley.
Cargos activos de Robert Ezzell
| Empresas | Cargo | Inicio |
|---|---|---|
| ATAI LIFE SCIENCES N.V. | Corporate Officer/Principal | 01/01/2021 |
Antiguos cargos conocidos de Robert Ezzell.
| Empresas | Cargo | Fin |
|---|---|---|
RenaMed Biologics, Inc.
 RenaMed Biologics, Inc. Medical/Nursing ServicesHealth Services RenaMed Biologics, Inc. provided clinical cellular therapy. The company was founded by H. David Humes, James P. Sherblom and Richard A. Andrews in 1995 and was headquartered in Lincoln, RI. | Corporate Officer/Principal | - |
| Harvard Medical School | Corporate Officer/Principal | - |
Glympse Bio, Inc.
 Glympse Bio, Inc. BiotechnologyHealth Technology Glympse Bio, Inc. develops modular nanoparticle sensors to create diagnostics for diseases. It uses engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. The company was founded in 2015 by Sangeeta Bhatia and Gabe A. Kwong and is headquartered in Cambridge, MA. | Consejero General | - |
Formación de Robert Ezzell.
| University of California, Berkeley | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ATAI LIFE SCIENCES N.V. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Glympse Bio, Inc.
Glympse Bio, Inc. BiotechnologyHealth Technology Glympse Bio, Inc. develops modular nanoparticle sensors to create diagnostics for diseases. It uses engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. The company was founded in 2015 by Sangeeta Bhatia and Gabe A. Kwong and is headquartered in Cambridge, MA. | Health Technology |
RenaMed Biologics, Inc.
RenaMed Biologics, Inc. Medical/Nursing ServicesHealth Services RenaMed Biologics, Inc. provided clinical cellular therapy. The company was founded by H. David Humes, James P. Sherblom and Richard A. Andrews in 1995 and was headquartered in Lincoln, RI. | Health Services |
- Bolsa de valores
- Insiders
- Robert Ezzell
